Date: 03-Apr-2020

Jubilant Life Sciences Arm Receives EIR From US FDA For US Salisbury Facility

Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that Jubilant Pharma Limited, a wholly owned subsidiary of the company, through one of its wholly owned subsidiaries, has received the establishment inspection report (EIR) with Voluntary Action Indicated (VAI) status from the US FDA for its solid dosage facility at Salisbury, Maryland USA.

This is in respect of the inspection conducted by the regulatory agency from February 24 to 28, 2020.

With the receipt of the EIR, the inspection stands successfully closed.

Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery and development solutions businesses.